Form D · Biotechnology
NOVALAR PHARMACEUTICALS INC
San Diego, CA · CIK 0001130807
Offering snapshot reported Jul 23, 2010 · SEC filing
- Reported sold
- $1M Offering amount: $2.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 23, 2010 | Initial | $1,000,999 | No comparison | 5 | SEC filing |
| Nov 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 27, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-145399
Source: Form D, filed Jul 23, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian H. Dovey | Director |
| Donna Janson | Director, Executive |
| John J. Savarese | Director |
| Lowell E. Sears | Director |
| Steven J. Semmelmayer | Director |
| Robert S. Stefanovich | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12555 High Bluff Drive, Suite 300
San Diego, CA, 92130
San Diego, CA, 92130